Foley & Lardner LLP represented HPI Holdings LLC, an Oklahoma City-based operator of hospitals, outpatient centers and clinics, in the sale of a controlling interest in HPI to a joint venture owned by Integris and United Surgical Partners International. The deal closed on November 1, 2018.
As described by the parties to the venture, the deal allows for the combination of HPI’s comprehensive service offerings and convenience of care, the INTEGRIS system’s continuum of care in Oklahoma and the management infrastructure and capabilities of USPI. It also establishes an affiliation of more than 1,300 physicians, representing a wide variety of specialties with practices across metro Oklahoma City.
Foley partner Roger Strode served as lead counsel for HPI and was supported by partners Steve Gerenraich, Jana Anderson Kolarik, John Palmer, Alan Rutenberg, Michael Woolever; of counsel Don Romano; Senior Counsel Ben Dryden; and Associate Melissa Conroy.
As described by the parties to the venture, the deal allows for the combination of HPI’s comprehensive service offerings and convenience of care, the INTEGRIS system’s continuum of care in Oklahoma and the management infrastructure and capabilities of USPI. It also establishes an affiliation of more than 1,300 physicians, representing a wide variety of specialties with practices across metro Oklahoma City.
Foley partner Roger Strode served as lead counsel for HPI and was supported by partners Steve Gerenraich, Jana Anderson Kolarik, John Palmer, Alan Rutenberg, Michael Woolever; of counsel Don Romano; Senior Counsel Ben Dryden; and Associate Melissa Conroy.
People
Related News
18 December 2024
Press Releases
Foley Names Jen Cafferty Patton as Chief Operating Officer to Further Drive Strategic Growth and Business Performance
Foley & Lardner LLP is pleased to announce Jen Cafferty Patton has been promoted to Chief Operating Officer to bolster the firm’s administrative leadership and advance its strategic priorities.
11 December 2024
Press Releases
Foley Releases Guide to Navigate Issues Stemming from Rapid Expansion of Antibody Drug Conjugates
Foley & Lardner LLP today released Antibody Drug Conjugates Keep Growing: What You Need to Know, a guide that answers many business and legal questions about the rapid expansion of this area of technology.
11 December 2024
Press Releases
Foley Expands East Coast Presence with IP Partner Brian Tomkins, Strengthening Capabilities in Technology and Health Care Sectors
Foley & Lardner LLP announced today that the firm has bolstered its Innovative Technology and Health Care & Life Sciences Sectors with the addition of Brian Tomkins as a partner in the Mechanical & Electromechanical Technologies Practice Group.